Status:
COMPLETED
Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Collaborating Sponsors:
EPS Corporation
Conditions:
Gastric Acid-related Diseases
Healthy
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare C13-CAC Breath Test with 24-hour Gastric pH Monitoring in Patients with Gastric Acid-related Diseases and Healthy Volunteers
Eligibility Criteria
Inclusion
- Patients with Gastric Acid-related diseases like peptic ulcer or gastroesophageal reflux disease in investigator's judgment
- Healthy subjects who are determined no history of Helicobacter pylori infections
Exclusion
- Patients with hypercalcemia
- Patients with hypothyroidism
- Patients with hyperparathyroidism
- History of upper gastrointestinal surgery or resection
- Any condition would limit the subject's ability to complete 24-hour gastric pH monitoring
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02225067
Start Date
August 1 2014
End Date
December 1 2014
Last Update
May 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OPHAC Hospital
Osaka, Osaka, Japan, 532-0003